Limitations, agreements, and source contact

Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors · Source last updated 2021-04-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

The study was terminated due to poor enrollment.

point Of Contact

email

puf1@cumc.columbia.edu

organization

Columbia University

phone

212-305-2254

title

Pamela U. Freda, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice